Tarben Pharmaceuticals Private Limited
About Tarben Pharmaceuticals Private Limited
Data last updated:
Tarben Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 11 January 2002.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2002PTC113781.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Meena Shukla and Abhaya Kumar Shukla.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at C – 16 Panchsheel Viharkhirki Extension, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2017, the company reported a revenue of ₹4.81 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹13,053 (net margin -2.7%) and EBITDA of ₹1.03 Lakh (EBITDA margin 21.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC – 16 Panchsheel Viharkhirki Extension, New Delhi, Delhi, India – 110017
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Tarben Pharmaceuticals Private Limited
FY 2018 filings availableTarben Pharmaceuticals Private Limited reported revenue of ₹4.81 Lakh (down 3% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA fell 22% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2014-15 to FY 2015-16in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹4.81 Lakh | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹1.03 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹13,053 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2016-17 | FY 2014-15 to FY 2015-16in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 21.5% | |
| Net Profit Margin | -2.7% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2014-15 to FY 2015-16, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tarben Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Tarben Pharmaceuticals Private Limited
Tarben Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Shukla | Director | 11 Jan 2002 | 24 Years 9 Months | As last reported |
| Abhaya Kumar Shukla | Director | 11 Jan 2002 | 24 Years 9 Months | As last reported |
Auditor Details
Tarben Pharmaceuticals Private Limited is audited by DEEPAK GULATI AND ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK GULATI AND ASSOCIATES | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Tarben Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Tarben Pharmaceuticals.
: available in the company report
Recent Activity
Tarben Pharmaceuticals Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Abhaya Kumar Shukla was appointed as Director on 11 Jan 2002.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Tarben Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Tarben Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 11 January 2002 and is registered under CIN U24239DL2002PTC113781. The company has been struck off by the Registrar of Companies and is no longer operational.
Tarben Pharmaceuticals had 2 directors:
- Meena Shukla - Director
- Abhaya Kumar Shukla - Director
The CIN (Corporate Identification Number) of Tarben Pharmaceuticals is U24239DL2002PTC113781. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Tarben Pharmaceuticals is at C – 16 Panchsheel Viharkhirki Extension, New Delhi, Delhi, India – 110017.
Tarben Pharmaceuticals was incorporated on 11 January 2002. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Tarben Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Tarben Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Abhaya Kumar Shukla was appointed as Director on 11 Jan 2002. Meena Shukla was appointed as Director on 11 Jan 2002.
Tarben Pharmaceuticals can be reached at its registered office: C – 16 Panchsheel Viharkhirki Extension, New Delhi, Delhi, India – 110017.